NCT03675204 is a clinical trial of No intervention in Breast Milk Collection, sponsored by Heilongjiang Feihe Dairy Co. Ltd..

Who is sponsoring NCT03675204?

NCT03675204 is sponsored by Heilongjiang Feihe Dairy Co. Ltd..

What drugs are being tested in NCT03675204?

Interventions in NCT03675204: No intervention.

What condition does NCT03675204 study?

NCT03675204 studies Breast Milk Collection.

Is NCT03675204 still recruiting?

NCT03675204 is currently completed. Last updated 31 July 2019.

Last reviewed 2019-07-31 · How we verify

NCT03675204

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Establishment of the Breast Milk Database in China

Completed Last updated 31 July 2019

What this trial tests

trial testing No intervention in Breast Milk Collection in 1,800 participants. Completed in 30 December 2018.

Timeline

19 October 2016

Primary endpoint
1 August 2018

30 December 2018

Quick facts

Lead sponsor	Heilongjiang Feihe Dairy Co. Ltd.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,800
Start date	19 October 2016
Primary completion	1 August 2018
Estimated completion	30 December 2018

Drugs / interventions tested

No intervention

Conditions studied

Breast Milk Collection — all drugs for Breast Milk Collection →

Sponsor

Heilongjiang Feihe Dairy Co. Ltd. — full company profile →

Who can join

Adults 25 to 35, female only, with Breast Milk Collection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Collect breast milk samples in various administrative regions of China to measure the nutrients in breast milk; analyze the composition of nutrients; and establish the database of breast milk in China.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Human Milk Metabolomics Are Related to Maternal Adiposity, Infant Growth Rate and Allergies: The Chinese Human Milk Project.
Zhang W, Li K, Zheng C, Sun H, et al · · 2022 · cited 8× · PMID 35631238 · DOI 10.3390/nu14102097
Comparative Analysis of Triglycerides From Different Regions and Mature Lactation Periods in Chinese Human Milk Project (CHMP) Study.
Zhu H, Liang A, Wang X, Zhang W, et al · · 2021 · cited 6× · PMID 35004826 · DOI 10.3389/fnut.2021.798821
Comparative Proteomics of Human Milk From Eight Cities in China During Six Months of Lactation in the Chinese Human Milk Project Study.
Sari RN, Pan J, Zhang W, Li Y, et al · · 2021 · cited 5× · PMID 34458300 · DOI 10.3389/fnut.2021.682429
An investigation of association between human milk mineral patterns and infant growth.
Sun H, Xie Q, Zhou Y, Liu Y, et al · · 2024 · cited 2× · PMID 38962446 · DOI 10.3389/fnut.2024.1387956
Dynamic Variations in Endogenous Peptides in Chinese Human Milk Across Lactation and Geographical Regions.
Chen B, Li K, Wang X, Zhang W, et al · · 2025 · PMID 41097212 · DOI 10.3390/nu17193131

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Breast Milk Collection

Currently open trials in the same condition.

NCT06342674 — Effect of Breast Milk Circadian Properties on Infant's Growth Parameters and Absorption of Nutrients · NA · recruiting
NCT05986539 — Early Life Feeding Exposure and Infant Immune and Health Status. · recruiting
NCT05111990 — Human Milk and Its Effect on Infant's Metabolism and Infant Gut Microbiome · active not recruiting

Other Heilongjiang Feihe Dairy Co. Ltd. trials

Trials by the same sponsor.

NCT07484035 — Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA) · NA · not yet recruiting
NCT06569797 — Effect of Oligosaccharides and Optimizing Multiple Nutrients to Infant Formula on Growth and Development of Infants · NA · recruiting
NCT06158659 — Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula · NA · completed
NCT06159088 — Improved Gut Health Outcomes Associated With Probiotics Fortified With Hydrolyzed Whey Protein in Infant Formula · NA · completed
NCT06146387 — Improved Cognitive Outcomes Associated With Feihe HMO With DHA/ARA in Infant Formula · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03675204 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Heilongjiang Feihe Dairy Co. Ltd.
Last refreshed: 31 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03675204.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing